Trials / Completed
CompletedNCT00329147
Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
A Randomized, Open-Label, Cross-Over Drug Interaction Study to Evaluate the Effects of Desvenlafaxine (DVS SR) and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects of multiple doses of DVS SR and paroxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desvenlafaxine SR | |
| DRUG | desipramine | |
| DRUG | paroxetine |
Timeline
- Start date
- 2006-05-01
- Completion
- 2006-06-01
- First posted
- 2006-05-24
- Last updated
- 2007-12-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00329147. Inclusion in this directory is not an endorsement.